Evidence map›Paper›PMID 40136359›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Barriers and Facilitators to Delivering Multifactorial Risk Assessment and Communication for Personalized Breast Cancer Screening: A Qualitative Study Exploring Implementation in Canada.

Meghan J Walker, Anna Neely, Antonis C Antoniou, Mireille J M Broeders, Jennifer D Brooks, Tim Carver, Jocelyne Chiquette, Douglas F Easton, Andrea Eisen, Laurence Eloy and 12 more

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. PRS-BCJournal of medical genetics · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Meghan J WalkerOntario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.ORCID 0000-0003-4189-7507
Anna NeelyOntario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Antonis C AntoniouCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK.
Mireille J M BroedersIQ Health Science Department, Radboud University Medical Center, 6525 EP Nijmegen, The Netherlands.ORCID 0000-0002-8741-8148
Jennifer D BrooksDalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.ORCID 0000-0001-7574-4256
Tim CarverCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK.ORCID 0000-0003-1508-3091
Jocelyne ChiquetteCHU de Québec-Université Laval Research Center, Québec City, QC G1V 4G2, Canada.ORCID 0000-0003-3556-4677
Douglas F EastonCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK.
Andrea EisenOntario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Laurence EloyProgramme Québécois de Cancérologie, Ministère de la Santé et des Services Sociaux, Quebec City, QC G1S 2M1, Canada.
D Gareth R EvansDepartment of Medical Genetics and Cancer Epidemiology, The University of Manchester, Manchester M13 9PL, UK.ORCID 0000-0002-8482-5784
Samantha FienbergOntario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.
Yann JolyCentre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.
Raymond H KimOntario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.ORCID 0000-0002-2147-8674
Bartha M KnoppersCentre of Genomics and Policy, McGill University, Montreal, QC H3A 0G1, Canada.ORCID 0000-0001-7004-2722
Aisha K LoftersDalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.ORCID 0000-0002-7322-0894
Hermann NabiCHU de Québec-Université Laval Research Center, Québec City, QC G1V 4G2, Canada.
Nora PashayanCentre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge CB1 8RN, UK.
Tracy L StockleyDivision of Clinical Laboratory Genetics, University Health Network, Toronto, ON M5G 2C4, Canada.ORCID 0000-0002-4476-9722
Michel DorvalCHU de Québec-Université Laval Research Center, Québec City, QC G1V 4G2, Canada.ORCID 0000-0002-3207-8211
Jacques SimardCHU de Québec-Université Laval Research Center, Québec City, QC G1V 4G2, Canada.ORCID 0000-0001-6906-3390
Anna M ChiarelliOntario Health (Cancer Care Ontario), Toronto, ON M5G 2L3, Canada.

Funding

CHU de Québec Foundation N/ACHU de Québec-Université Laval Research Center N/ACIHR 155865Genome Canada 13529Ontario Research Fund N/AQuébec Breast Cancer Foundation N/AQuébec Ministry of Economy, Science and Innovation N/A
6 · The paper itself

Abstract

Many jurisdictions are considering a shift to risk-stratified breast cancer screening; however, evidence on the feasibility of implementing it on a population scale is needed. We conducted a prospective cohort study in the PERSPECTIVE I&I project to produce evidence on risk-stratified breast screening and recruited 3753 participants to undergo multifactorial risk assessment from 2019-2021. This qualitative study explored the perspectives of study personnel on barriers and facilitators to delivering multifactorial risk assessment and risk communication. One focus group and three one-on-one interviews were conducted and a thematic analysis conducted which identified five themes: (1) barriers and facilitators to recruitment for multifactorial risk assessment, (2) barriers and facilitators to completion of the risk factor questionnaire, (3) additional resources required to implement multifactorial risk assessment, (4) the need for a person-centered approach, and (5) and risk literacy. While risk assessment and communication processes were successful overall, key barriers were identified including challenges with collecting comprehensive breast cancer risk factor information and limited resources to execute data collection and risk communication activities on a large scale. Risk assessment and communication processes will need to be optimized for large-scale implementation to ensure they are efficient but robust and person-centered.

Indexed as

Breast NeoplasmsEarly Detection of CancerAdultCanadaCommunicationFemaleFocus GroupsHumansMiddle AgedPrecision MedicineProspective StudiesQualitative ResearchRisk Assessmentbarriersbreast cancer screeningimplementationpersonalized screeningqualitative researchrisk-stratification

Identifiers

PMID40136359
PMCPMC11941251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.